Marimed (MRMD) Treasury Shares (2017 - 2026)

Marimed (MRMD) has 10 years of Treasury Shares data on file, last reported at $8.8 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $8.8 million, down 16.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.8 million (down 16.68% YoY), and the FY2025 annual result was $9.9 million, up 28.3% from the prior year.
• Treasury Shares rose to $545000.0 in Q2 2018 per MRMD's latest filing, from $45000.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $10.6 million in Q2 2025 and troughed at $1.6 million in Q4 2022.
• A 5-year average of $6.6 million and a median of $6.3 million in 2023 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2026: Treasury Shares jumped 1904.63% in 2022, then fell 16.68% in 2026.
• A 2-year view of Treasury Shares shows it stood at $45000.0 in 2017, then soared by 1111.11% to $545000.0 in 2018.
• Business Quant data shows MRMD's Treasury Shares at $545000.0 in Q2 2018, $45000.0 in Q1 2018, and $45000.0 in Q4 2017.